CIK 0001479681
- Accelerated filer
Nutex Health Inc.
Sign in to watch- Ticker
- NUTX
- Exchange
- Nasdaq
- Industry
- Services-Business Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113363609
- Phone
- +1 713-660-0557
- Business address
- 1776 YORKTOWN ST, SUITE 700, HOUSTON, TX, 77056
- Former names
- Nutex Health, Inc., Clinigence Holdings, Inc., iGambit, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,493
- in 1 filing
Net −$43,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-12 | Meiri David Director | Purchase | +31,746 | $20,000.00 | $634.9M | 266,627 |
| 2020-08-12 | Creem Mitchell Director | Purchase | +31,746 | $20,000.00 | $634.9M | 31,746 |
| 2020-08-12 | Breslin Terence Martin Director | Purchase | +31,746 | $20,000.00 | $634.9M | 724,496 |
| 2020-08-12 | Waters John J Director | Purchase | +31,746 | $20,000.00 | $634.9M | 31,746 |
| 2020-08-12 | Hosseinion Warren Director | Returned to the company | +31,746 | $20,000.00 | $634.9M | 237,521 |
| 2020-08-05 | Fawcett Mark Director | Purchase · Director Stock Option (right to buy) | +85,120 | 85,120 | ||
| 2020-07-13 | Margolin Jacob Director | Purchase | +228,346 | $179,800.00 | $41.1B | 574,998 |
| 2020-06-30 | Margolin Jacob Director | Purchase | +31,034 | $45,000.00 | $1.4B | 349,652 |
| 2020-06-30 | Schimmel Lawrence Chief Executive Officer | Purchase | +44,828 | $65,000.00 | $2.9B | 126,355 |
| 2020-05-11 | Margolin Jacob Director | Grant or award · Director Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-05-11 | Breslin Terence Martin Director | Grant or award · Director Stock Option (right to buy) | +30,000 | 85,120 | ||
| 2020-05-11 | Creem Mitchell Director | Grant or award · Director Stock Option (right to buy) | +30,000 | 85,120 | ||
| 2020-05-11 | Schimmel Lawrence Chief Medical Officer | Grant or award · Officer Stock Option (right to buy) | +30,000 | 45,168 | ||
| 2020-05-11 | Hosseinion Warren Director | Grant or award · Director Stock Option (right to buy) | +100,000 | 221,590 | ||
| 2020-05-11 | Meiri David Director | Grant or award · Director Stock Option (right to buy) | +30,000 | 85,120 | ||
| 2020-05-11 | Waters John J Director | Grant or award · Director Stock Option (right to buy) | +50,000 | 174,283 | ||
| 2020-05-11 | Fawcett Mark Director | Grant or award · Director Stock Option (right to buy) | +30,000 | 88,718 | ||
| 2020-05-11 | Luqman Elisa V Chief Financial Officer | Grant or award · Director Stock Option (right to buy) | +50,000 | 117,106 | ||
| 2020-01-27 | Hosseinion Warren Chief Executive Officer | Purchase · Director Stock Option (right to buy) | +800,000 | 800,000 | ||
| 2020-01-27 | Fawcett Mark Director | Grant or award · Director Stock Option (right to buy) | +45,000 | 58,718 |
Page 10 of 12 · 225 trades